Havens Advisors LLC Pacific Biosciences Of California, Inc. Transaction History

Havens Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 02, 2021	SELL	$10.5 - $28.5 $588,000 - $1.6 Million	-56,000 Closed	0 $0
Q3 2020 Oct 08, 2020	SELL	$3.61 - $9.87 $866,400 - $2.37 Million	-240,000 Reduced 81.08%	56,000 $553,000
Q2 2020 Jul 24, 2020	SELL	$2.65 - $4.03 $33,559 - $51,035	-12,664 Reduced 4.1%	296,000 $1.02 Million
Q1 2020 Apr 21, 2020	BUY	$2.36 - $5.26 $708,691 - $1.58 Million	300,293 Added 3587.3%	308,664 $945,000
Q4 2019 Jan 27, 2020	SELL	$4.6 - $5.57 $2.62 Million - $3.18 Million	-570,129 Reduced 98.55%	8,371 $43,000
Q3 2019 Oct 09, 2019	SELL	$4.99 - $6.16 $164,670 - $203,280	-33,000 Reduced 5.4%	578,500 $2.99 Million
Q2 2019 Jul 12, 2019	SELL	$5.92 - $7.41 $156,880 - $196,365	-26,500 Reduced 4.15%	611,500 $3.7 Million
Q1 2019 Apr 15, 2019	BUY	$6.8 - $7.4 $81,600 - $88,800	12,000 Added 1.92%	638,000 $4.61 Million
Q4 2018 Jan 15, 2019	BUY	$3.99 - $7.82 $2.5 Million - $4.9 Million	626,000 New	626,000 $4.63 Million

258

234M

1.02M

965K

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $393M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Havens Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Havens Advisors LLC with notifications on news.